Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
|Study Design:||Time Perspective: Prospective|
|Official Title:||Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?|
- sustained viral response [ Time Frame: 72 weeks ] [ Designated as safety issue: No ]achieving SVR
|Study Start Date:||April 2008|
|Study Completion Date:||January 2009|
|Primary Completion Date:||October 2008 (Final data collection date for primary outcome measure)|
Other: Non Responders
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection.
Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01159613
|Ziv medical center liver unit|
|Safed, Israel, Israel|